Found 9 matching trials
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum N/A The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Show More Learn More & Join Trial
TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients PHASE2 The purpose of this study is to determine the effectiveness, safety, and to...
Show More Location
Multiple Locations
Learn More & Join Trial
HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS) PHASE1 Background:
Some people with Amyotrophic Lateral Sclerosis (ALS) have a hi...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin PHASE4 Pravastatin (Pravachol) is approved by the Food and Drug Administration (FD...
Show More Location
University of Colorado Denver
Learn More & Join Trial
DDI Study of BMS-663068 With Etravirine (ETR) and/or Darunavir (DVR) + Ritonavir (RTV) PHASE1 The purpose of this study is to determine if there is an interaction in hea...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy PHASE4 Basing in studies which have related the darunavir (DRV) virtual inhibitory...
Show More Location
Germans Trias i Pujol Hospital
Learn More & Join Trial
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN) PHASE3 The purpose of this study is to test if being treated with darunavir/ritona...
Show More Location
Multiple Locations
Learn More & Join Trial
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects PHASE4 Darunavir is a nonpeptidic protease inhibitor with a high genetic barrier t...
Show More Location
Ruth M. Rothstein CORE Center
Learn More & Join Trial
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy N/A IMPAACT P1026s is a Phase IV prospective clinical study to evaluate the pha...
Show More Location
UAB Pediatric Infectious Diseases CRS
Learn More & Join Trial